BANQUE SAUDI FRANSI
Basel III - Pillar III Disclosures
30 June 2024
Basel III - Pillar III Disclosures - 30 June 2024
Tables and templates | Page # |
KM1: Key metrics (at consolidated group level) | 3 |
CCA: Main features of regulatory capital instruments and of other TLAC-eligible instruments | 4 |
CC1: Composition of regulatory capital | 5 |
CC2: Reconciliation of regulatory capital to balance sheet | 6 |
ENC: Asset encumbrance | 7 |
OV1: Overview of RWA | 8 |
CR1: Credit quality of assets | 9 |
CR2: Changes in stock of defaulted loans and debt securities | 10 |
CR3: Credit risk mitigation techniques - overview | 11 |
CR4: Standardised approach - credit risk exposure and credit risk mitigation (CRM) effects | 12 |
CR5: Standardised approach - exposures by asset classes and risk weights | 13 |
CCR1: Analysis of CCR exposures by approach | 14 |
CCR3: Standardised approach - CCR exposures by regulatory portfolio and risk weights | 15 |
CCR5: Composition of collateral for CCR exposure | 16 |
CCR6: Credit derivatives exposures | 17 |
CCR8: Exposures to central counterparties | 18 |
MR1: Market risk under the standardised approach | 19 |
CVA1: The reduced basic approach for CVA (BA-CVA) | 20 |
CVA2: The full basic approach for CVA (BA-CVA) | 21 |
CVA3: The standardised approach for CVA (SA-CVA) | 22 |
CVA4: RWA flow statements of CVA risk exposures under SA-CVA | 23 |
LR1: Summary comparison of accounting assets vs leverage ratio exposure measure | 24 |
LR2: Leverage ratio common disclosure template | 25 |
LIQ1: Liquidity Coverage Ratio (LCR) | 26 |
LIQ2: Net Stable Funding Ratio (NSFR) | 27 |
CCyB1: Geographical distribution of credit exposures used in the calculation of the bank- | 28 |
specific countercyclical capital buffer requirement | |
2
Basel III - Pillar III Disclosures - 30 June 2024
KM1: Key metrics (at consolidated group level)
SR 000's | a | b | c | d | e | |
Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | ||
Available capital (amounts) | ||||||
1 | Common Equity Tier 1 (CET1) | 37,848,756 | 38,041,035 | 37,204,728 | 36,075,819 | 36,292,242 |
1a | Fully loaded ECL accounting model | 37,848,756 | 38,041,035 | 36,917,103 | 35,788,194 | 36,004,617 |
2 | Tier 1 | 42,848,756 | 43,041,035 | 42,204,728 | 41,075,819 | 41,292,242 |
2a | Fully loaded ECL accounting model Tier 1 | 42,848,756 | 43,041,035 | 41,917,103 | 40,788,194 | 41,004,617 |
3 | Total capital | 44,601,697 | 44,548,760 | 43,568,461 | 42,144,799 | 43,437,537 |
3a | Fully loaded ECL accounting model total capital | 44,601,697 | 44,548,760 | 43,280,836 | 41,857,174 | 43,149,912 |
Risk- | weighted assets (amounts) | |||||
4 | Total risk-weighted assets (RWA) | 246,687,676 | 234,255,461 | 223,023,190 | 219,332,886 | 217,276,610 |
4a | Total risk-weighted assets (pre-floor) | 246,687,676 | 234,255,461 | 223,023,190 | 219,332,886 | 217,276,610 |
Risk-based capital ratios as a percentage of RWA | ||||||
5 | CET1 ratio (%) | 15.34% | 16.24% | 16.68% | 16.45% | 16.70% |
5a | Fully loaded ECL accounting model CET1 (%) | 15.34% | 16.24% | 16.55% | 16.32% | 16.57% |
5b | CET1 ratio (%) (pre-floor ratio) | 15.34% | 16.24% | 16.68% | 16.45% | 16.70% |
6 | Tier 1 ratio (%) | 17.37% | 18.37% | 18.92% | 18.73% | 19.00% |
6a | Fully loaded ECL accounting model Tier 1 ratio (%) | 17.37% | 18.37% | 18.79% | 18.60% | 18.87% |
6b | Tier 1 ratio (%) (pre-floor ratio) | 17.37% | 18.37% | 18.92% | 18.73% | 19.00% |
7 | Total capital ratio (%) | 18.08% | 19.02% | 19.54% | 19.21% | 19.99% |
7a | Fully loaded ECL accounting model total capital ratio (%) | 18.08% | 19.02% | 19.41% | 19.08% | 19.86% |
7b | Total capital ratio (%) (pre-floor ratio) | 18.08% | 19.02% | 19.54% | 19.21% | 19.99% |
Additional CET1 buffer requirements as a percentage of RWA | ||||||
8 | Capital conservation buffer requirement (2.5% from 2019) (%) | 2.50% | 2.50% | 2.50% | 2.50% | 2.50% |
9 | Countercyclical buffer requirement (%) | 0.02% | 0.02% | 0.05% | 0.05% | 0.05% |
10 | Bank G-SIB and/or D-SIB additional requirements (%) | 0.50% | 0.50% | 0.50% | 0.50% | 0.50% |
11 | Total of bank CET1 specific buffer requirements (%) (row 8 + | 3.02% | 3.05% | 3.05% | 3.05% | 3.05% |
row 9 + row 10) | ||||||
12 | CET1 available after meeting the bank's minimum capital | 10.08% | 11.02% | 11.54% | 11.21% | 11.99% |
requirements (%) | ||||||
Basel III leverage ratio | ||||||
13 | Total Basel III leverage ratio exposure measure | 356,261,720 | 333,939,191 | 309,830,885 | 304,373,400 | 298,769,134 |
14 | Basel III leverage ratio (%) (including the impact of any | 12.03% | 12.89% | 13.62% | 13.50% | 13.82% |
applicable temporary exemption of central bank reserves) | ||||||
Fully loaded ECL accounting model Basel III leverage ratio | ||||||
14a | (including the impact of any applicable temporary exemption | 12.03% | 12.89% | 13.53% | 13.40% | 13.72% |
of central bank reserves) (%) | ||||||
14b | Basel III leverage ratio (%) (excluding the impact of any | 12.03% | 12.89% | 13.62% | 13.50% | 13.82% |
applicable temporary exemption of central bank reserves) | ||||||
Basel III leverage ratio (%) (including the impact of any | ||||||
14c | applicable temporary exemption of central bank reserves) | 12.03% | 12.89% | 13.62% | 13.50% | 13.82% |
incorporating mean values for SFT assets | ||||||
Basel III leverage ratio (%) (excluding the impact of any | ||||||
14d | applicable temporary exemption of central bank reserves) | 12.03% | 12.89% | 13.62% | 13.50% | 13.82% |
incorporating mean values for SFT assets | ||||||
Liquidity | Coverage Ratio (LCR) | |||||
15 | Total high-quality liquid assets (HQLA) | 43,855,835 | 43,162,866 | 43,141,206 | 42,448,292 | 38,108,681 |
16 | Total net cash outflow | 23,446,643 | 26,066,588 | 22,626,135 | 25,055,551 | 21,866,729 |
17 | LCR ratio (%) | 187% | 166% | 196% | 171% | 180% |
Net Stable Funding Ratio (NSFR) | ||||||
18 | Total available stable funding | 177,278,132 | 166,833,232 | 160,835,285 | 156,256,015 | 155,759,131 |
19 | Total required stable funding | 150,162,938 | 143,845,681 | 137,740,306 | 134,761,722 | 134,157,626 |
20 | NSFR ratio | 118% | 116% | 117% | 116% | 116% |
3
Basel III - Pillar III Disclosures - 30 June 2024 | ||
CCA - Main features of regulatory capital instruments and of other TLAC-eligible instruments | ||
a | ||
Quantitative / qualitative | ||
information | ||
1 | Issuer | Banque Saudi Fransi |
Unique identifier (eg Committee on Uniform Security | ||
2 | Identification Procedures (CUSIP), International | N/A |
Securities Identification Number (ISIN) or Bloomberg | ||
identifier for private placement) | ||
3 | Governing law(s) of the instrument | Saudi Arabian law |
Means by which enforceability requirement of Section | ||
3a | 13 of the TLAC Term Sheet is achieved (for other | |
TLAC-eligible instruments governed by foreign law) | ||
4 | Transitional Basel III rules | Additional Tier I |
5 | Post-transitional Basel III rules | Eligible |
6 | Eligible at solo/group/group and solo | Group & Solo |
7 | Instrument type (refer to SACAP) | Subordinated sukuk |
8 | Amount recognised in regulatory capital (currency in | SAR 5,000,000 |
millions, as of most recent reporting date) | ||
9 | Par value of instrument | SAR 5,000,000 |
10 | Accounting classification | Equity |
11 | Original date of issuance | 04 November 2020 |
12 | Perpetual or dated | Perpetual |
13 | Original maturity date | N/A |
14 | Issuer call subject to prior SAMA approval | Yes |
Optional call date, contingent call dates and | In compliance with Basel III, call date is equal to or greater than 5 years and the Sukuk may be | |
15 | redeemed early due to a capital event, tax event or at the option of the Bank as described in the terms | |
redemption amount | ||
and conditions of the Sukuk | ||
16 | Subsequent call dates, if applicable | As above |
Coupons / dividends | ||
17 | Fixed or floating dividend/coupon | Fixed |
18 | Coupon rate and any related index | 4.5% p.a. |
19 | Existence of a dividend stopper | Yes |
20 | Fully discretionary, partially discretionary or | Fully discretionary |
mandatory | ||
21 | Existence of step-up or other incentive to redeem | No |
22 | Non-cumulative or cumulative | Non Cumulative |
23 | Convertible or non-convertible | Non Convertible |
24 | If convertible, conversion trigger(s) | N/A |
25 | If convertible, fully or partially | N/A |
26 | If convertible, conversion rate | N/A |
27 | If convertible, mandatory or optional conversion | N/A |
28 | If convertible, specify instrument type convertible | N/A |
into | ||
29 | If convertible, specify issuer of instrument it | N/A |
converts into | ||
30 | Writedown feature | Yes |
31 | If writedown, writedown trigger(s) | Terms of contract of the instrument provide the legal basis for SAMA to trigger write-down (a |
contractual approach) | ||
32 | If writedown, full or partial | Write-down fully or partial |
33 | If writedown, permanent or temporary | Permanent |
34 | If temporary write-down, description of writeup | N/A |
mechanism | ||
34a | Type of subordination | Subordinated |
Position in subordination hierarchy in liquidation | ||
35 | (specify instrument type immediately senior to | N/A |
instrument in the insolvency creditor hierarchy of the | ||
legal entity concerned). | ||
36 | Non-compliant transitioned features | N/A |
37 | If yes, specify non-compliant features | N/A |
Instructions
Banks are required to complete the template for each outstanding regulatory capital instrument and, in the case of G-SIBs,TLAC-eligible instruments (banks should insert "NA" if the question is not applicable).
Banks are required to report each instrument, including common shares, in a separate column of the template, such that the completed Table CCA would provide a "main features report" that summarises all of the regulatory capital and TLAC-eligible instruments of the banking group. G-SIBs disclosing these instruments should group them under three sections (horizontally along the table) to indicate whether they are for meeting (i) only capital (but not TLAC) requirements; (ii) both capital and TLAC requirements; or (iii) only TLAC (but not capital) requirements.
4
Basel III - Pillar III Disclosures - 30 June 2024
CC1 - Composition of regulatory capital
a | b | Commentary to explain any significant changes | ||
Source based on reference numbers/letters of | ||||
SR 000's | over the reporting period and the key drivers of | |||
Amounts | the balance sheet under the regulatory scope of | |||
such change | ||||
consolidation | ||||
Common Equity Tier 1 capital: instruments and reserves | ||||
1 | Directly issued qualifying common share (and equivalent for non-joint stock | |||
companies) capital plus related stock surplus | 12,053,572 | |||
2 | Retained earnings | 26,631,370 | ||
3 | Accumulated other comprehensive income (and other reserves) | (1,672,242) | ||
4 | Directly issued capital subject to phase-out from CET1 capital (only applicable to non- | |||
joint stock companies) | ||||
5 | Common share capital issued by subsidiaries and held by third parties (amount allowed | |||
in group CET1 capital) | ||||
6 | Common Equity Tier 1 capital before regulatory adjustments | 37,012,700 | ||
Common | Equity Tier 1 capital: regulatory adjustments | |||
7 | Prudent valuation adjustments | |||
8 | Goodwill (net of related tax liability) | |||
9 | Other intangibles other than mortgage servicing rights (MSR) (net of related tax | |||
liability) | ||||
10 | Deferred tax assets (DTA) that rely on future profitability, excluding those arising from | |||
temporary differences (net of related tax liability) | ||||
11 | Cash flow hedge reserve | 1,039,427 | ||
12 | Shortfall of provisions to expected losses | |||
13 | Securitisation gain on sale (as set out in SACAP4.1.4) | |||
14 | Gains and losses due to changes in own credit risk on fair valued liabilities | |||
15 | Defined benefit pension fund net assets | |||
16 | Investments in own shares (if not already subtracted from paid-in capital on reported | (203,371) | ||
balance sheet) | ||||
17 | Reciprocal cross-holdings in common equity | |||
Investments in the capital of banking, financial and insurance entities that are outside | ||||
18 | the scope of regulatory consolidation, where the bank does not own more than 10% of | |||
the issued share capital (amount above 10% threshold) | ||||
Significant investments in the common stock of banking, financial and insurance | ||||
19 | entities that are outside the scope of regulatory consolidation (amount above 10% | |||
threshold) | ||||
20 | MSR (amount above 10% threshold) | |||
21 | DTA arising from temporary differences (amount above 10% threshold, net of related | |||
tax liability) | ||||
22 | Amount exceeding the 15% threshold | |||
23 | Of which: significant investments in the common stock of financials | |||
24 | Of which: MSR | |||
25 | Of which: DTA arising from temporary differences | |||
26 | National specific regulatory adjustments | |||
27 | Regulatory adjustments applied to Common Equity Tier 1 capital due to insufficient | |||
Additional Tier 1 and Tier 2 capital to cover deductions | ||||
28 | Total regulatory adjustments to Common Equity Tier 1 capital | 836,056 | ||
29 | Common Equity Tier 1 capital (CET1) | 37,848,756 | ||
Additional Tier 1 capital: instruments | ||||
30 | Directly issued qualifying additional Tier 1 instruments plus related stock surplus | 5,000,000 | ||
31 | Of which: classified as equity under applicable accounting standards | |||
32 | Of which: classified as liabilities under applicable accounting standards | |||
33 | Directly issued capital instruments subject to phase-out from additional Tier 1 capital | |||
Additional Tier 1 instruments (and CET1 instruments not included in row 5) issued by | ||||
34 | subsidiaries and held by third parties (amount allowed in group additional Tier 1 | |||
capital) | ||||
35 | Of which: instruments issued by subsidiaries subject to phase-out | |||
36 | Additional Tier 1 capital before regulatory adjustments | 5,000,000 | ||
Additional Tier 1 capital: regulatory adjustments | ||||
37 | Investments in own additional Tier 1 instruments | |||
38 | Reciprocal cross-holdings in additional Tier 1 instruments | |||
Investments in the capital of banking, financial and insurance entities that are outside | ||||
39 | the scope of regulatory consolidation, where the bank does not own more than 10% of | |||
the issued common share capital of the entity (amount above 10% threshold) | ||||
40 | Significant investments in the capital of banking, financial and insurance entities that | |||
are outside the scope of regulatory consolidation | ||||
41 | National specific regulatory adjustments | |||
42 | Regulatory adjustments applied to additional Tier 1 capital due to insufficient Tier 2 | |||
capital to cover deductions | ||||
43 | Total regulatory adjustments to additional Tier 1 capital | - | ||
44 | Additional Tier 1 capital (AT1) | 5,000,000 | ||
45 | Tier 1 capital (T1 = CET1 + AT1) | 42,848,756 | ||
Tier 2 | capital: instruments and provisions | |||
46 | Directly issued qualifying Tier 2 instruments plus related stock surplus | |||
47 | Directly issued capital instruments subject to phase-out from Tier 2 capital | |||
48 | Tier 2 instruments (and CET1 and AT1 instruments not included in rows 5 or 34) issued | |||
by subsidiaries and held by third parties (amount allowed in group Tier 2) | ||||
49 | Of which: instruments issued by subsidiaries subject to phase-out | |||
50 | Provisions | 1,752,941 | ||
51 | Tier 2 capital before regulatory adjustments | 1,752,941 | ||
Tier 2 | capital: regulatory adjustments | |||
52 | Investments in own Tier 2 instruments | |||
53 | Reciprocal cross-holdings in Tier 2 instruments and other TLAC liabilities | |||
Investments in the capital and other TLAC liabilities of banking, financial and insurance | ||||
54 | entities that are outside the scope of regulatory consolidation, where the bank does | |||
not own more than 10% of the issued common share capital of the entity (amount | ||||
above 10% threshold) | ||||
Investments in the other TLAC liabilities of banking, financial and insurance entities | ||||
that are outside the scope of regulatory consolidation and where the bank does not | ||||
54a | own more than 10% of the issued common share capital of the entity: amount | |||
previously designated for the 5% threshold but that no longer meets the conditions | ||||
(for G-SIBs only) | ||||
Significant investments in the capital and other TLAC liabilities of banking, financial | ||||
55 | and insurance entities that are outside the scope of regulatory consolidation (net of | |||
eligible short positions) | ||||
56 | National specific regulatory adjustments | |||
57 | Total regulatory adjustments to Tier 2 capital | - | ||
58 | Tier 2 capital | 1,752,941 | ||
59 | Total regulatory capital (= Tier 1 + Tier2) | 44,601,697 | ||
60 | Total risk-weighted assets | 246,687,676 | Increase in Credit RWA | |
Capital | adequacy ratios and buffers | |||
61 | Common Equity Tier 1 capital (as a percentage of risk-weighted assets) | 15.34% | ||
62 | Tier 1 capital (as a percentage of risk-weighted assets) | 17.37% | ||
63 | Total capital (as a percentage of risk-weighted assets) | 18.08% | ||
Institution-specific buffer requirement (capital conservation buffer plus | ||||
64 | countercyclical buffer requirements plus higher loss absorbency requirement, | |||
expressed as a percentage of riskweighted assets) | 3.02% | |||
65 | Of which: capital conservation buffer requirement | 2.50% | ||
66 | Of which: bank-specific countercyclical buffer requirement | 0.02% | ||
67 | Of which: higher loss absorbency requirement | 0.50% | ||
68 | Common Equity Tier 1 capital (as a percentage of risk-weighted assets) | |||
available after meeting the bank's minimum capital requirements | 10.08% | |||
National | minima (if different from Basel III) | |||
69 | National minimum Common Equity Tier 1 capital adequacy ratio (if different from Basel | |||
III minimum) | n/a | |||
70 | National minimum Tier 1 capital adequacy ratio (if different from Basel III minimum) | n/a | ||
71 | National minimum Total capital adequacy ratio (if different from Basel III minimum) | n/a | ||
Amounts below the thresholds for deduction (before risk-weighting) | ||||
72 | Non-significant investments in the capital and other TLAC liabilities of other financial | |||
entities | ||||
73 | Significant investments in the common stock of financial entities | |||
74 | MSR (net of related tax liability) | |||
75 | DTA arising from temporary differences (net of related tax liability) | |||
Applicable caps on the inclusion of provisions in Tier 2 capital | ||||
76 | Provisions eligible for inclusion in Tier 2 capital in respect of exposures subject to | |||
standardised approach (prior to application of cap) | 1,752,941 | |||
77 | Cap on inclusion of provisions in Tier 2 capital under standardised approach | 2,934,447 | ||
78 | Provisions eligible for inclusion in Tier 2 capital in respect of exposures subject to | |||
internal ratings based approach (prior to application of cap) | n/a | |||
79 | Cap for inclusion of provisions in Tier 2 capital under internal ratings-based approach | n/a | ||
Capital | instruments subject to phase-out arrangements (only applicable between 1 | |||
80 | Current cap on CET1 instruments subject to phase-out arrangements | |||
81 | Amount excluded from CET1 capital due to cap (excess over cap after redemptions and | |||
maturities) | ||||
82 | Current cap on AT1 instruments subject to phase-out arrangements | |||
83 | Amount excluded from AT1 capital due to cap (excess over cap after redemptions and | |||
maturities) | ||||
84 | Current cap on Tier 2 instruments subject to phase-out arrangements | |||
85 | Amount excluded from Tier 2 capital due to cap (excess over cap after redemptions | |||
and maturities) | ||||
5
Basel III - Pillar III Disclosures - 30 June 2024
CC2 - Reconciliation of regulatory capital to balance sheet
a | b | c | ||
Balance sheet as | Under | |||
in published | ||||
SR 000's | regulatory scope | |||
financial | Reference | |||
of consolidation | ||||
statements | ||||
As at period-end | As at period-end | |||
Assets | ||||
1 | Cash and balances with SAMA | 11,577,948 | 11,577,948 | |
2 | Items in the course of collection from other banks | |||
3 | Trading portfolio assets | 588,147 | 588,147 | |
4 | Financial assets designated at fair value | |||
5 | Derivative financial instruments | 6,207,275 | 6,207,275 | |
6 | Due from banks and other FI | 11,742,226 | 11,742,226 | |
7 | Loans and advances | 197,160,066 | 197,160,066 | |
8 | Investments at amortised cost | 27,712,690 | 27,712,690 | |
9 | Investments at FVOCI | 27,205,026 | 27,205,026 | |
10 | Current and deferred tax assets | - | ||
11 | Other assets and other real estate | 4,548,281 | 4,548,281 | |
12 | Investments in associates and joint ventures | 9,695 | 9,695 | |
13 | Goodwill and intangible assets | - | - | |
Of which: goodwill | ||||
Of which: other intangibles (excluding MSR) | ||||
Of which: MSR | ||||
14 | Property, equipment and RoU | 2,075,122 | 2,075,122 | |
15 | Total assets | 288,826,476 | 288,826,476 | |
Liabilities | ||||
16 | Due to SAMA, banks and other FI | 24,856,768 | 24,856,768 | |
17 | Items in the course of collection due to other banks | - | ||
18 | Customers' deposits | 196,247,577 | 196,247,577 | |
19 | Repurchase agreements and other similar secured | |||
borrowing | ||||
20 | Trading portfolio liabilities | |||
21 | Financial liabilities designated at fair value | |||
22 | Derivative financial instruments | 7,102,424 | 7,102,424 | |
23 | Debt securities and term loans | 12,490,055 | 12,490,055 | |
24 | Other liabilities | 6,320,323 | 6,320,323 | |
25 | Current and deferred tax liabilities | - | - | |
Of which: deferred tax liabilities (DTL) related to goodwill | ||||
Of which: DTL related to intangible assets (excluding | ||||
MSR) | ||||
Of which: DTL related to MSR | ||||
26 | Subordinated liabilities | |||
27 | Provisions | |||
28 | Retirement benefit liabilities | |||
29 | Total liabilities | 247,017,147 | 247,017,147 | |
Shareholders' equity | ||||
30 | Paid-in share capital | 17,053,572 | 17,053,572 | |
Of which: amount eligible for CET1 capital | 12,053,572 | 12,053,572 | ||
Of which: amount eligible for AT1 capital | 5,000,000 | 5,000,000 | ||
31 | Retained earnings | 26,631,370 | 26,631,370 | |
32 | Accumulated other comprehensive income | -1,875,613 | -1,875,613 | |
33 | Total shareholders' equity | 41,809,329 | 41,809,329 |
6
Basel III - Pillar III Disclosures - 30 June 2024
ENC: Asset encumbrance
a | b | c | ||
SR 000's | Encumbered | Unencumbered | Total | |
Assets | Assets | |||
The assets on the balance sheet would be | ||||
1 | disaggregated; there can be as much disaggregation as | 17,152,346 | 271,674,130 | 288,826,476 |
desired | ||||
7
Basel III - Pillar III Disclosures - 30 June 2024
OV1: Overview of RWA
a | b | c | ||||
Minimum | Drivers behind significant differences during the | |||||
SR 000's | RWA | capital | ||||
quarter | ||||||
requirements | ||||||
Jun-24 | Mar-24 | Jun-24 | ||||
1 | Credit risk (excluding counterparty credit risk) | 226,823,191 | 214,654,533 | 18,145,855 | ||
2 | Of which: standardised approach (SA) | 226,823,191 | 214,654,533 | 18,145,855 | Due to increase in Risk weighted assets | |
3 | Of which: foundation internal ratings-based(F-IRB) approach | |||||
4 | Of which: supervisory slotting approach | |||||
5 | Of which: advanced internal ratings-based(A-IRB) approach | |||||
6 | Counterparty credit risk (CCR) | 3,987,003 | 3,488,759 | 318,960 | ||
7 | Of which: standardised approach for counterparty credit risk | 3,987,003 | 3,488,759 | 318,960 | ||
8 | Of which: IMM | |||||
9 | Of which: other CCR | |||||
10 | Credit valuation adjustment (CVA) | 3,945,595 | 3,982,974 | 315,648 | ||
Equity positions under the simple risk weight approach and the | ||||||
11 | internal model method during the five-year linear phase-in | |||||
period | ||||||
12 | Equity investments in funds - look-through approach | |||||
13 | Equity investments in funds - mandate-based approach | |||||
14 | Equity investments in funds - fall-back approach | |||||
15 | Settlement risk | |||||
16 | Securitisation exposures in banking book | |||||
17 | Of which: securitisation IRB approach (SEC-IRBA) | |||||
18 | Of which: securitisation external ratings-based approach (SEC- | |||||
ERBA), including internal assessment approach (IAA) | ||||||
19 | Of which: securitisation standardised approach (SEC-SA) | |||||
20 | Market risk | 2,756,746 | 3,226,993 | 220,540 | ||
21 | Of which: standardised approach (SA) | 2,756,746 | 3,226,993 | 220,540 | ||
22 | Of which: internal model approach (IMA) | |||||
23 | Capital charge for switch between trading book and banking | |||||
book | ||||||
24 | Operational risk | 9,175,141 | 8,902,202 | 734,011 | ||
25 | Amounts below the thresholds for deduction (subject to 250% | |||||
risk weight) | ||||||
26 | Output floor applied | |||||
27 | Floor adjustment (before application of transitional cap) | |||||
28 | Floor adjustment (after application of transitional cap) | |||||
29 | Total (1 + 6 + 10 + 11 + 12 + 13 + 14 + 15 + 16 + 20 + 23 + | 246,687,676 | 234,255,461 | 19,735,014 | ||
24 + 25 + 28) | ||||||
8
Basel III - Pillar III Disclosures - 30 June 2024
CR1: Credit quality of assets
a | b | c | d | e | f | g | ||
Of which ECL accounting | ||||||||
Gross carrying values of | provisions for credit losses | Of which ECL | ||||||
on SA exposures | ||||||||
SR 000's | accounting | Net | ||||||
Allowances/ | ||||||||
provisions for | values | |||||||
impairments | Allocated in | Allocated in | ||||||
credit losses on | (a+b-c) | |||||||
Defaulted | Nondefaulted | regulatory | regulatory | |||||
IRB exposures | ||||||||
exposures | exposures | category of | category of | |||||
Specific | General | |||||||
1 | Loans | 1,879,252 | 198,322,456 | 3,041,642 | 1,331,193 | 1,710,449 | 197,160,066 | |
2 | Debt Securities | 54,354,281 | 12,317 | 12,317 | 54,341,964 | |||
3 | Off-balance sheet exposures | 504,879 | 65,635,000 | 173,304 | 147,859 | 25,445 | 65,966,575 | |
4 | Total | 2,384,131 | 318,311,737 | 3,227,263 | 1,479,052 | 1,748,211 | - | 317,468,605 |
9
Basel III - Pillar III Disclosures - 30 June 2024 | |||
CR2: Changes in stock of defaulted loans and debt securities | |||
SR 000's | a | ||
1 | Defaulted loans and debt securities at end | 1,920,781 | |
of the previous reporting period | |||
2 | Loans and debt securities that have defaulted | 252,088 | |
since the last reporting period | |||
3 | Returned to non-defaulted status | 16,727 | |
4 | Amounts written off | 248,429 | |
5 | Other changes | 28,461 | |
6 | Defaulted loans and debt securities at end | 1,879,252 | |
of the reporting period (1+2-3-4+5) | |||
10
